paxilline has been researched along with DDD MPGNII in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harita, Y; Hattori, M; Hattori, S; Hayashi, K; Horita, S; Igarashi, T; Ishizuka, K; Kajiho, Y; Kanda, S; Kosako, H; Kurihara, H; Matsunaga, A; Miura, K; Oka, A; Sekine, T; Tsurumi, H | 1 |
1 other study(ies) available for paxilline and DDD MPGNII
Article | Year |
---|---|
Epithelial protein lost in neoplasm modulates platelet-derived growth factor-mediated adhesion and motility of mesangial cells.
Topics: Actins; Adolescent; Animals; Cell Adhesion; Cell Movement; Cells, Cultured; Child; Cytoskeletal Proteins; Gene Expression; Glomerulonephritis, IGA; Glomerulonephritis, Membranoproliferative; Humans; MAP Kinase Signaling System; Mesangial Cells; Microfilament Proteins; Paxillin; Platelet-Derived Growth Factor; Rats; RNA, Messenger; Thy-1 Antigens | 2014 |